Skip to content

Clinical trials

Cellulitis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cellulitis Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20102
20111
20121
20171
20181
20201
20211
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting1
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ottawa Hospital Research Institute3
Wyeth is now a wholly owned subsidiary of Pfizer2
Affinium Pharmaceuticals, Ltd1
Duke University1
Durata Therapeutics Inc., an affiliate of Allergan plc1
GlaxoSmithKline1
Kelowna General Hospital1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Toronto Metropolitan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cellulitis15
Emergencies2
Soft Tissue Infections2
Wound Infection2
Abscess1
Adrenal Insufficiency1
Arrhythmias, Cardiac1
Attention Deficit Disorder with Hyperactivity1
Bacterial Infections1
Bronchopulmonary Dysplasia1

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.